» Articles » PMID: 38022694

Computational Analysis of Five Neurodegenerative Diseases Reveals Shared and Specific Genetic Loci

Overview
Specialty Biotechnology
Date 2023 Nov 29
PMID 38022694
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases (ND) are heterogeneous disorders of the central nervous system that share a chronic and selective process of neuronal cell death. A computational approach to investigate shared genetic and specific loci was applied to 5 different ND: Amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), Multiple sclerosis (MS), and Lewy body dementia (LBD). The datasets were analyzed separately, and then we compared the obtained results. For this purpose, we applied a genetic correlation analysis to genome-wide association datasets and revealed different genetic correlations with several human traits and diseases. In addition, a clumping analysis was carried out to identify SNPs genetically associated with each disease. We found 27 SNPs in AD, 6 SNPs in ALS, 10 SNPs in PD, 17 SNPs in MS, and 3 SNPs in LBD. Most of them are located in non-coding regions, with the exception of 5 SNPs on which a protein structure and stability prediction was performed to verify their impact on disease. Furthermore, an analysis of the differentially expressed miRNAs of the 5 examined pathologies was performed to reveal regulatory mechanisms that could involve genes associated with selected SNPs. In conclusion, the results obtained constitute an important step toward the discovery of diagnostic biomarkers and a better understanding of the diseases.

Citing Articles

NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders.

Egunlusi A, Joubert J Pharmaceuticals (Basel). 2024; 17(5).

PMID: 38794209 PMC: 11124131. DOI: 10.3390/ph17050639.

References
1.
Sanford A . Lewy Body Dementia. Clin Geriatr Med. 2018; 34(4):603-615. DOI: 10.1016/j.cger.2018.06.007. View

2.
Brooks B, Berry J, Ciepielewska M, Liu Y, Zambrano G, Zhang J . Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis. EClinicalMedicine. 2022; 52:101590. PMC: 9358426. DOI: 10.1016/j.eclinm.2022.101590. View

3.
Bette S, Shpiner D, Singer C, Moore H . Safinamide in the management of patients with Parkinson's disease not stabilized on levodopa: a review of the current clinical evidence. Ther Clin Risk Manag. 2018; 14:1737-1745. PMC: 6152599. DOI: 10.2147/TCRM.S139545. View

4.
van Dyck C, Swanson C, Aisen P, Bateman R, Chen C, Gee M . Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2022; 388(1):9-21. DOI: 10.1056/NEJMoa2212948. View

5.
Wainberg M, Andrews S, Tripathy S . Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis. Alzheimers Res Ther. 2023; 15(1):113. PMC: 10273745. DOI: 10.1186/s13195-023-01244-3. View